首页 | 本学科首页   官方微博 | 高级检索  
     

中央导管相关血流感染管理成效序贯分析
引用本文:曹煜隆,单娇,龚志忠,匡季秋,高燕. 中央导管相关血流感染管理成效序贯分析[J]. 中国感染控制杂志, 2021, 20(9): 822-826. DOI: 10.12138/j.issn.1671-9638.20218424
作者姓名:曹煜隆  单娇  龚志忠  匡季秋  高燕
作者单位:1. 北京大学人民医院感控处, 北京 100044;2. 北京积水潭医院疾控处, 北京 100035;3. 清华大学公共管理学院, 北京 100084
基金项目:国家临床重点专科能力建设项目经费资助;北京市临床重点专科项目经费资助;中美新发和再发传染病合作项目(5U2GGH000018)
摘    要:
目的 旨在评估采取感染控制干预措施预防中央导管相关血流感染(CLABSI)的管理成效.方法 计算机系统检索2010年1月—2020年12月国内外数据库中关于CLABSI预防控制的国内研究,提取原始研究中的报告数据,合并OR值及95%置信区间(CI),并对干预方式进行归纳.结果 共检索263篇研究,其中142篇纳入最终分...

关 键 词:中央导管相关血流感染  血管导管相关血流感染  医院感染管理  质量改进  序贯分析  医院感染
收稿时间:2021-05-20

Trial sequential analysis on effectiveness in the management of central line-associated bloodstream infection
CAO Yu-long,SHAN Jiao,GONG Zhi-zhong,KUANG Ji-qiu,GAO Yan. Trial sequential analysis on effectiveness in the management of central line-associated bloodstream infection[J]. Chinese Journal of Infection Control, 2021, 20(9): 822-826. DOI: 10.12138/j.issn.1671-9638.20218424
Authors:CAO Yu-long  SHAN Jiao  GONG Zhi-zhong  KUANG Ji-qiu  GAO Yan
Affiliation:1. Department of Healthcare-associated Infection Control, Peking University People's Hospital, Beijing 100044, China;2. Department of Disease Control, Beijing Jishuitan Hospital, Beijing 100035, China;3. School of Public Policy&Management, Tsinghua University, Beijing 100084, China
Abstract:
Objective To evaluate the management effectiveness of infection control intervention measures in preventing central line-associated bloodstream infection (CLABSI). Methods The domestic studies on prevention and control of CLABSI in domestic and foreign databases from January 2010 to December 2020 were retrieved through computer system, the reported data in the original study were extracted, OR value and 95% confidence interval (CI) were combined, intervention methods were summarized. Results A total of 263 studies were retrieved, 142 of which were included in the final analysis, prevention and control of CLABSI in recent 10 years has achieved remar-kable results (OR=0.26, 95%CI:0.24-0.29), about 68.53% of CLABSI can be prevented. There is no heterogeneity among studies, a total of 43 614 patients are involved, far exceeding the cut off points of trial sequential analysis. Conclusion Prevention and control of CLABSI in China has achieved remarkable results in recent ten years, there is no need to carry out more trial to prove it, follow-up quality improvement study can be carried out according to the 2021 guidelines, further reduce the rate of vascular catheter-associated infection.
Keywords:central line-associated bloodstream infection  vascular catheter-associated infection  healthcare-associated infection management  quality improvement  trial sequential analysis  healthcare-associated infection  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号